Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (3) , 301-306
- https://doi.org/10.1023/a:1008342013224
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Chemotherapy for advanced gastric cancer: where do we stand?Journal of Clinical Oncology, 1997
- Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.Journal of Clinical Oncology, 1997
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.Journal of Clinical Oncology, 1997
- Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survivalCancer, 1996
- A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)Annals of Oncology, 1994
- Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): Not simply two of a kindAnnals of Oncology, 1994
- The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)Cancer Treatment Reviews, 1993
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- Screening for gastric cancerWorld Journal of Surgery, 1989
- Randomized study of combination chemotherapy in unresectable gastric cancerCancer, 1984